Clinical Trials for CSPC Pharmaceutical

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CSPC Pharmaceutical

Clinical Trials (5)

NCT06704685
A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI
PHASE3Not yet recruiting
40 participants
Started: Dec 1, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors0 locations
NCT06224842
Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL
PHASE1/PHASE2Recruiting
30 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05604638
Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
PHASE4Not yet recruiting
600 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors0 locations
NCT05603884
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
PHASE2Recruiting
66 participants
Started: Dec 1, 2022 · Completed: Dec 31, 2026
2 conditions8 sponsors1 location
NCT06220097
Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies
PHASE2Active, not recruiting
28 participants
Started: Feb 1, 2022 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location